Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

John Messenger to Incidence

This is a "connection" page, showing publications John Messenger has written about Incidence.

 
Connection Strength
 
 
 
0.293
 
  1. Valle JA, McCoy LA, Maddox TM, Rumsfeld JS, Ho PM, Casserly IP, Nallamothu BK, Roe MT, Tsai TT, Messenger JC. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2017 Apr; 10(4).
    View in: PubMed
    Score: 0.092
  2. Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020 08; 96(2):336-345.
    View in: PubMed
    Score: 0.029
  3. Ream K, Sandhu A, Valle J, Weber R, Kaizer A, Wiktor DM, Borne RT, Tumolo AZ, Kunkel M, Zipse MM, Schuller J, Tompkins C, Rosenberg M, Nguyen DT, Cleveland JC, Fullerton D, Carroll JD, Messenger J, Sauer WH, Aleong RG, Tzou WS. Ambulatory Rhythm Monitoring to?Detect?Late High-Grade Atrioventricular Block Following Transcatheter Aortic?Valve?Replacement. J Am Coll Cardiol. 2019 05 28; 73(20):2538-2547.
    View in: PubMed
    Score: 0.027
  4. Jackson LR, Ju C, Zettler M, Messenger JC, Cohen DJ, Stone GW, Baker BA, Effron M, Peterson ED, Wang TY. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study. JACC Cardiovasc Interv. 2015 Dec 21; 8(14):1880-9.
    View in: PubMed
    Score: 0.021
  5. Brennan JM, Sketch MH, Dai D, Trilesskaya M, Al-Hejily W, Rao SV, Brilakis E, Messenger JC, Shaw RE, Anstrom KJ, Peterson ED, Douglas PS. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(?) CathPCI Registry(?) (2005-2009). Catheter Cardiovasc Interv. 2016 Jan 01; 87(1):43-9.
    View in: PubMed
    Score: 0.020
  6. Schuller JL, Zipse MM, Krantz MJ, Blaker B, Salcedo E, Groves BM, Messenger JC, Beaty B, Sauer WH. Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy. J Interv Cardiol. 2015 Feb; 28(1):90-7.
    View in: PubMed
    Score: 0.020
  7. Wang TY, McCoy L, Henry TD, Effron MB, Messenger JC, Cohen DJ, Mark DB, Stone GW, Zettler M, Singh M, Fonarow GC, Peterson ED. Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. J Am Coll Cardiol. 2014 Apr 29; 63(16):1700-2.
    View in: PubMed
    Score: 0.018
  8. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, Spertus JA. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014 Jan; 7(1):1-9.
    View in: PubMed
    Score: 0.018
  9. Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis J, Messenger J, Resnic FS, Fitzgerald S. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. J Invasive Cardiol. 2012 Jul; 24(7):328-34.
    View in: PubMed
    Score: 0.017
  10. Cram P, House JA, Messenger JC, Piana RN, Horwitz PA, Spertus JA. Percutaneous coronary intervention outcomes in US hospitals with varying structural characteristics: analysis of the NCDR?. Am Heart J. 2012 Feb; 163(2):222-9.e1.
    View in: PubMed
    Score: 0.016
  11. Schuchert A, Carlson M, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M. Atrial overdrive pacing and incidence of heart failure-related adverse events in permanently paced patients. J Interv Card Electrophysiol. 2007 Jun; 19(1):55-60.
    View in: PubMed
    Score: 0.012
  12. Heldman D, Mulvihill D, Nguyen H, Messenger JC, Rylaarsdam A, Evans K, Castellanet MJ. True incidence of pacemaker syndrome. Pacing Clin Electrophysiol. 1990 Dec; 13(12 Pt 2):1742-50.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)